The government's own press release, published on 2 June 2026 (the day before Starmer's speech), directly confirms this claim. The official GOV.UK announcement is titled "Major expansion of research and treatment for prostate cancer" and states: "Men at highest risk of prostate cancer will benefit from research to find the best screening strategy and more treatment choices under a major new £20 million package announced today (2 June 2026)." It further describes the package as "over £20 million to improve prostate cancer research and treatment." The breakdown includes up to £18 million from the NIHR to expand the TRANSFORM trial (enabling all eligible Black men to be invited to stage 2), up to £2.8 million in capital funding for focal therapy provision, and additional commitments around GP guidance and digital PSA testing via the NHS App. Starmer's claim that the government is "funding a major expansion of cancer research and treatment, backed by £20 million, to help men at the highest risk" accurately reflects this announcement. The speech context makes clear this is about prostate cancer specifically (addressing the chair of the prostate cancer APPG), and the official government source confirms every element of the claim: the funding amount (~£20 million), the focus on research and treatment expansion, and the targeting of men at highest risk. Sources: - GOV.UK, "Major expansion of research and treatment for prostate cancer" (2 June 2026), https://www.gov.uk/government/news/major-expansion-of-research-and-treatment-for-prostate-cancer - BBC News, "Prostate cancer screening only for 'a few thousand' at risk men" (2 June 2026), https://www.bbc.co.uk/news/articles/cn0pvxe5jgzo - ITV News, "Prostate screening only for 'most at risk' men, government says" (2 June 2026), https://www.itv.com/news/2026-06-02/prostate-screening-only-for-most-at-risk-men-government-says